EGFR and neoplasm: LncMLETA1 facilitates tumor metastasis via regulating EGFR and IGF1R expression and its level in patient plasma is correlated with tumor metastasis and a higher TNM stage, indicating its potential as a prognostic biomarker for metastasis of lung cancer [147].